AZITHROMYCIN DIN 02343347
Status: Cancelled Pre Market
Holder: COBALT PHARMACEUTICALS COMPANY
Molecule: AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE)
Health Canada record
| Active ingredient(s) | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) 250 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01FA10 AZITHROMYCIN |
| Original market date | |
| Current status date | 01-Sep-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Cobalt Pharmaceuticals Company — licence 100618, not currently licensed, last inspection rating C (2018-11-09).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02465604 | AZITHROMYCIN FOR INJECTION, USP | AURO PHARMA INC | Powder For Solution | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) 500 MG | Marketed |
| 02358816 | AZITHROMYCIN FOR INJECTION, USP | STRIDES PHARMA CANADA INC | Powder For Solution | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) 500 MG | Approved |
| 02531429 | AZITHROMYCIN FOR INJECTION, USP | EUGIA PHARMA INC. | Powder For Solution | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) 500 MG | Marketed |
| 02255340 | ACT AZITHROMYCIN | ACTAVIS PHARMA COMPANY | Tablet | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) 250 MG | Cancelled Post Market |
| 02256088 | ACT AZITHROMYCIN | ACTAVIS PHARMA COMPANY | Tablet | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) 600 MG | Cancelled Post Market |
| 02363380 | AVA-AZITHROMYCIN | AVANSTRA INC | Powder For Suspension | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) 200 MG | Cancelled Post Market |
| 02363372 | AVA-AZITHROMYCIN | AVANSTRA INC | Powder For Suspension | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) 100 MG | Cancelled Post Market |
| 02330911 | AZITHROMYCIN | SANIS HEALTH INC | Tablet | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) 600 MG | Cancelled Post Market |
| 02342030 | AZITHROMYCIN | 4513347 CANADA INC. | Tablet | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) 250 MG | Cancelled (Unreturned Annual) |
| 02343355 | AZITHROMYCIN | COBALT PHARMACEUTICALS COMPANY | Tablet | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) 600 MG | Cancelled Pre Market |
| 02342049 | AZITHROMYCIN | 4513347 CANADA INC. | Tablet | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) 600 MG | Cancelled (Unreturned Annual) |
| 02368846 | AZITHROMYCIN FOR INJECTION | STERIMAX INC | Powder For Solution | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) 500 MG | Dormant |
| 02334976 | AZITHROMYCIN FOR INJECTION, USP | HOSPIRA HEALTHCARE ULC | Powder For Solution | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) 500 MG | Cancelled Pre Market |
| 02334844 | AZITHROMYCIN FOR INJECTION, USP | HOSPIRA HEALTHCARE ULC | Powder For Solution | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) 500 MG | Cancelled Post Market |
| 02385473 | AZITHROMYCIN FOR INJECTION, USP | MYLAN PHARMACEUTICALS ULC | Powder For Solution | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) 500 MG | Cancelled Post Market |
| 02275317 | RIVA AZITHROMYCIN | LABORATOIRE RIVA INC. | Tablet | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE) 600 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 11049 | 2010-02-15 | Abbreviated New Drug Submission (ANDS) | Additional product name |